Daifuku; Richard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Daifuku; Richard.The latest application filed is for "method of treatment of tp53 wild-type tumors with 2',2'-difluoro-5-aza-2'-deoxycytidine or prodrugs thereof".
- Daifuku; Richard - Mercer Island WA
- DAIFUKU; Richard - Mercier Island WA
| Patent | Date |
|---|---|
| Silylated pyrimidine prodrugs and methods of their use Grant 10,479,807 - Daifuku , et al. Nov | 2019-11-19 |
| Method Of Treatment Of Tp53 Wild-type Tumors With 2',2'-difluoro-5-aza-2'-deoxycytidine Or Prodrugs Thereof App 20190054103 - DAIFUKU; Richard | 2019-02-21 |
| Vitamin E-nucleoside prodrugs Grant 10,071,112 - Daifuku September 11, 2 | 2018-09-11 |
| Silylated Pyrimidine Prodrugs And Methods Of Their Use App 20170305941 - Daifuku; Richard ; et al. | 2017-10-26 |
| Vitamin E-Nucleoside Prodrugs App 20170298088 - Daifuku; Richard | 2017-10-19 |
| Fluorinated pyrimidine analogs and methods of use thereof Grant 9,493,500 - Daifuku , et al. November 15, 2 | 2016-11-15 |
| Fluorinated Pyrimidine Analogs And Methods Of Use Thereof App 20140024612 - Daifuku; Richard ; et al. | 2014-01-23 |
| Prodrugs of heteroaryl compounds Grant 8,324,379 - Daifuku , et al. December 4, 2 | 2012-12-04 |
| Prodrugs of Heteroaryl Compounds App 20110224434 - Daifuku; Richard ; et al. | 2011-09-15 |
| Prodrugs of heteroaryl compounds Grant 7,982,034 - Daifuku , et al. July 19, 2 | 2011-07-19 |
| Mutagenic Nucleoside Analogs for the Treatment of Viral Disease App 20100279968 - Li; Ling ; et al. | 2010-11-04 |
| 1,3,5-triazines for treatment of viral diseases Grant 7,772,197 - Daifuku , et al. August 10, 2 | 2010-08-10 |
| Mutagenic nucleoside analogs for the treatment of viral disease Grant 7,648,967 - Li , et al. January 19, 2 | 2010-01-19 |
| 1,3,5-triazines for treatment of viral diseases Grant 7,642,247 - Daifuku , et al. January 5, 2 | 2010-01-05 |
| Prodrugs of heteroaryl compounds Grant 7,589,092 - Daifuku , et al. September 15, 2 | 2009-09-15 |
| Prodrugs Of Heteroaryl Compounds App 20090209505 - Daifuku; Richard ; et al. | 2009-08-20 |
| Prodrugs Of Heteroaryl Compounds App 20090192099 - Daifuku; Richard ; et al. | 2009-07-30 |
| Prodrugs Of Heteroaryl Compounds App 20080249097 - Daifuku; Richard ; et al. | 2008-10-09 |
| Mutagenic Heterocycles App 20080033172 - Daifuku; Richard ; et al. | 2008-02-07 |
| Mutagenic Heterocycles App 20080009496 - Daifuku; Richard ; et al. | 2008-01-10 |
| Prodrugs Of Heteroaryl Compounds App 20070219200 - Daifuku; Richard ; et al. | 2007-09-20 |
| 1,3,5-Triazines for Treatment of Viral Diseases App 20070207973 - Daifuku; Richard ; et al. | 2007-09-06 |
| Prodrugs of heteroaryl compounds Grant 7,244,732 - Daifuku , et al. July 17, 2 | 2007-07-17 |
| Mutagenic nucleoside analogs for the treatment of viral disease Grant 7,244,717 - Li , et al. July 17, 2 | 2007-07-17 |
| 1,3,5-triazines For Treatment Of Viral Diseases App 20070142310 - Daifuku; Richard ; et al. | 2007-06-21 |
| Mutagenic nucleoside analogs for the treatment of viral disease App 20060142240 - Li; Ling ; et al. | 2006-06-29 |
| Prodrugs of heteroaryl compounds App 20050014752 - Daifuku, Richard ; et al. | 2005-01-20 |
| 1,3,5-Triazines for treatment of viral diseases App 20040127436 - Daifuku, Richard ; et al. | 2004-07-01 |
| Mutagenic nucleoside analogs for the treatment of viral disease App 20030170872 - Li, Ling ; et al. | 2003-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 